Inspire Medical Systems Stock EBITDA
| 2DR Stock | EUR 174.80 3.20 1.86% |
Inspire Medical Systems fundamentals help investors to digest information that contributes to Inspire Medical's financial success or failures. It also enables traders to predict the movement of Inspire Stock. The fundamental analysis module provides a way to measure Inspire Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inspire Medical stock.
Inspire |
Inspire Medical Systems Company EBITDA Analysis
Inspire Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Inspire Medical EBITDA | (40.73 M) |
Most of Inspire Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inspire Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Inspire Medical Systems reported earnings before interest,tax, depreciation and amortization of (40.73 Million). This is 104.64% lower than that of the Healthcare sector and 106.34% lower than that of the Medical Devices industry. The ebitda for all Germany stocks is 101.04% higher than that of the company.
Inspire EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inspire Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inspire Medical could also be used in its relative valuation, which is a method of valuing Inspire Medical by comparing valuation metrics of similar companies.Inspire Medical is currently under evaluation in ebitda category among its peers.
Inspire Fundamentals
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0692 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.12) % | |||
| Current Valuation | 6.62 B | |||
| Shares Outstanding | 29.05 M | |||
| Shares Owned By Insiders | 2.15 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Price To Book | 15.49 X | |||
| Price To Sales | 19.86 X | |||
| Revenue | 407.86 M | |||
| Gross Profit | 341.74 M | |||
| EBITDA | (40.73 M) | |||
| Net Income | (44.88 M) | |||
| Cash And Equivalents | 226.14 M | |||
| Cash Per Share | 8.31 X | |||
| Total Debt | 15.8 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 13.43 X | |||
| Book Value Per Share | 17.10 X | |||
| Cash Flow From Operations | 11.57 M | |||
| Earnings Per Share | (1.53) X | |||
| Target Price | 257.9 | |||
| Number Of Employees | 755 | |||
| Beta | 1.47 | |||
| Market Capitalization | 7.05 B | |||
| Total Asset | 564.88 M | |||
| Net Asset | 564.88 M |
About Inspire Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inspire Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inspire Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inspire Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Inspire Stock
When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock. Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.